All filters
Slidesets
Liver transplantation for HCV and HBV in The Czech Republic- Soña Frankova, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
The EpiTer-2 database- Robert Flisiak, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Case Study: The changing IV drug use problem/pattern and what that means to the epidemic- Mojca Maticic, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Mortality and causes of death among HIV/HCV co-infected persons in the Eastern European country of Georgia- Akaki Abutidze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
HCV resistance-associated variants among HCV treatment naïve HIVcoinfected patients in Ukraine. A pilot study- Marta Vasylyev
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Hepatitis B cure strategies: how far are we?- Heiner Wedemeyer, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
New delivery systems and long acting antiretroviral drugs- David Back, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Early results of pre-exposure prophylaxis program in Georgia- Nikoloz Chkhartishvili
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
The Regression of Liver Fibrosis in HCV Cirrhotic Patients Who Registered SVR after DAA Therapy- Anca Leustean
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Insulin-like growth factor and platelet-derived growth factor in liver cells of patients with chronic hepatitis C at different stages of fibrosis- Igor Tikhonov
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
HIV PrEP- Pep Coll, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
The HIV epidemic in CEE countries- Oana Săndulescu, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
How would the epidemic evolve in the future- David van de Vijver
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
Long acting HIV drugs for prevention: what are the data?- Pep Coll, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
HIV transmission in the migrant population- Dimitrios Paraskevis, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
Is there a need for HCV resistance testing in routine diagnostics and patient treatment? - Routine HCV genotyping and resistance testing and performance of the Sentosa SQ HCV Genotyping v2.0 assaysing next-generation sequencing- Robert Ehret
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
The prevalence of resistance associated substitutes through Europe The European prevalence of hepatitis C virus NS5A polymorphisms- Stephanie Popping
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
The current status of PrEP in Europe- Pep Coll, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
Influence of resistance in the future- Richard Harrigan, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
A 5 amino-acid insertion in the C-terminal region of HIV-2 integrase impacts phenotypic susceptibility to the five integrase inhibitors- Quentin Le Hingrat
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
A new wild-type HIV in the era of transmitted drug resistance- Kristof Theys, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
Resistance mutations to different classes of antiretroviral agents predict virological failure in HIV+ patients with low level viremia: a retrospective study from the ARCA cohort- Francesca Lombardi
Presented at:
European Meeting on HIV & Hepatitis 2018